Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Back to our regularly scheduled program

<< Previous

Bullboard Posts

Next >>

Comment by hmmmmmmmmon Jan 06, 2024 8:22pm

159 Views

Post# 35814196

RE:RE:RE:RE:RE:RE:RE:RE:Back to our regularly scheduled program

I "convieniently" used the last update of 2022 to the last update of 2023.

But you say the last 6 months tells a different story. So lets look..

June 20, 2023 64 patients enrolled.

Dec 14, 2023 81 patients enrolled

17 patients in 6 months = 2.8 per month

69 divided by 2.8 = 24.6 months

Still 2+ years.. What is your excuse with those numbers? Are we to use numbers when investing? or stories based on wishes?

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale